Fig. 4From: Clinical characteristics of patients from Quebec, Canada, with Morquio A syndrome: a longitudinal observational studyIndividual patient MPS-HAQ scores over time for the domains of self-care, mobility, and care services, following treatment with elosulfase alfa. Note that lower scores indicate a better outcome. 1171A>G: founder pathogenic variant; HAQ: Health Assessment QuestionnaireBack to article page